Oncology

Advocacy group helps breast cancer patient overcome fear and channel her anger to battle the disease.

New technique uses chromatin as a way of identifying small molecule drugs for cancer.

Current standard treatment for advanced ovarian cancer is carboplatin, paclitaxel, and bevacizumab.

Macrophages can penetrate the surrounding walls that protect pancreatic cancer from chemotherapy.

Research supports weekly chemotherapy without bevacizumab in treating advanced ovarian cancer.

Tyverb and Herceptin combination shows significant promise treating HER2 positive breast cancer.

Quality of life and overall health concerns plague patients who survive cancer.

The bacteria porphyromonas gingivalis is found in 61% of patients with esophageal squamous cell carcinoma.

Radiotherapy and panobinostat show promise treating glioblastoma.

Increased inflammation in obese women is thought to increase the risk of breast cancer.

Laser system allows temporary window in blood-brain barrier to effectively target glioblastoma.

Immune checkpoint blockades have shown long-term control of different types of cancer.

PET scans are not recommended for long-term monitoring of cancer recurrence.

Study suggests low dose chemotherapy that controls tumor growth instead of eradicating the disease may be a more effective long term treatment.

Recent advances and updates in oncology and cancer drug development.

Xalkori gives new option to patients with the rare and difficult to treat ROS-1 gene mutation in NSCLC.

Expanded use of crizotinib treats patients with ROS1-positive metastatic non–small cell lung cancer.

Harnessing T cells may lead to significant new cancer treatments.

Obesity carries increased risk for diabetes, cardiovascular disease, and lymphomas.

Cancer drug called nutlins activate the P53 gene to trigger blood cancer cell death instead of temporarily suppressing the disease.

Foods with a high glycemic index raise blood sugar levels and stimulate the production of insulin

Signaling pathway may be vital in treating colorectal cancer patients.

Keytruda found to improve overall survival compared with chemotherapy in patients with non-small cell lung cancer.

Keytruda showed an improvement in overall survival compared with chemotherapy in patients with NSCLC.

New colorectal cancer screening guidelines call for biweekly screenings for adults aged 50 to 74 years for colorectal cancer with FOBT or flexible sigmoidoscopy every 10 years.

New method examines the genetic background of tumors for more effective prostate cancer therapy.

Treatment shows promise in fighting lymphoma in early studies.

New analysis provides faster tests and lower costs for women with estrogen positive-receptor (ER-positive) breast cancer.